Is Realty Income the Best Dividend Stock to Buy Long-Term?
Realty Income (NYSE:O) is a longstanding real estate investment trust…
Sell
15
PRCXF Quote, Financials, Valuation and Earnings
Last price:
$0.70
Seasonality move
:
--
Day range:
$0.70 - $0.70
52-week range:
$0.70 - $0.70
Dividend yield:
0%
P/E ratio:
13.94x
P/S ratio:
0.32x
P/B ratio:
1.02x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$100.5M
Revenue:
$307M
EPS (TTM):
$0.05
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Green Cross Health has -- downside to fair value with a price target of -- per share.
PRCXF vs. S&P 500
-
Over the past 5 trading days, Green Cross Health has underperformed the S&P 500 by -7.02% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Green Cross Health does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Green Cross Health has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Green Cross Health reported revenues of --.
Earnings Growth
-
Green Cross Health has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Green Cross Health reported earnings per share of --.
Enterprise value:
181.4M
EV / Invested capital:
--
Price / LTM sales:
0.32x
EV / EBIT:
11.60x
EV / Revenue:
0.58x
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
6.45x
Gross Profit (TTM):
$180.3M
Return On Assets:
3.08%
Net Income Margin (TTM):
2.3%
Return On Equity:
7.12%
Return On Invested Capital:
4.37%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-04-10 | 2024-04-10 | 2024-04-10 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $74.4M | $78.4M | $71.7M | $49.1M | $57.1M | |
| Total Assets | $246.9M | $256.9M | $238M | $224.7M | $249M | |
| Current Liabilities | $74.4M | $81.9M | $80M | $55.8M | $59.8M | |
| Total Liabilities | $150.9M | $146.3M | $137.6M | $127.2M | $141.5M | |
| Total Equity | $96M | $110.5M | $100.4M | $97.5M | $107.5M | |
| Total Debt | $86.8M | $74M | $69.2M | $80.2M | $90.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-04-10 | 2024-04-10 | 2024-04-10 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
PRCXF
Sector
Market Cap
$100.5M
$260.2M
Price % of 52-Week High
100%
70.97%
Dividend Yield
0%
0%
Shareholder Yield
--
3.03%
1-Year Price Total Return
--
-13.38%
Beta (5-Year)
--
0.416
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
80.92%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.70
200-day SMA
Sell
Level
$0.70
Bollinger Bands (100)
Sell
Level
0.7 - 0.7
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$0.70
Relative Strength Index (RSI14)
Sell
Level
0.00
ADX Line
Neutral
Level
9.33
Williams %R
Buy
Level
0
50-day SMA
Sell
Level
$0.70
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Neutral
Level
--
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Buy
CA Score
(Annual)
Level (0.0556)
--
Beneish M-Score
(Annual)
Level (--)
--
Momentum Score
Level (--)
Sell
Ohlson Score
Level (3.045)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Green Cross Health Ltd is engaged in providing healthcare services in New Zealand. The reportable segments of the group are Pharmacy services, Medical services. The majority of the revenue is generated from the Pharmacy services segment. Its pharmacy services segment includes operations like providing pharmacy services through consolidated stores, equity-accounted investments, and franchise stores under the Unichem and Life Pharmacy brands. The medical service segment provides complete family healthcare services through general practitioners, accidents, and medical centers, with many operating under The Doctors Brand. Its community health segment provides services directly to the community to support independent living.
Stock Forecast FAQ
In the current month, PRCXF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PRCXF average analyst price target in the past 3 months is --.
-
Where Will Green Cross Health Stock Be In 1 Year?
According to analysts, the consensus estimate is that Green Cross Health share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Green Cross Health?
Analysts are divided on their view about Green Cross Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Green Cross Health is a Sell and believe this share price will rise from its current level to --.
-
What Is Green Cross Health's Price Target?
The price target for Green Cross Health over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is PRCXF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Green Cross Health is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of PRCXF?
You can purchase shares of Green Cross Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Green Cross Health shares.
-
What Is The Green Cross Health Share Price Today?
Green Cross Health was last trading at $0.70 per share. This represents the most recent stock quote for Green Cross Health. Yesterday, Green Cross Health closed at $0.70 per share.
-
How To Buy Green Cross Health Stock Online?
In order to purchase Green Cross Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Archer Aviation a Buy, Sell or Hold?
Vertical takeoff and landing (eVTOL) aircraft sound futuristic but that’s…
Down 50%, Is Dell Technologies a Buy?
Dell (NYSE:DELL)’s share price has been on a roller coaster…
Stock Ideas
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Sell
33
BULZ alert for Apr 10
MicroSectors Solactive FANG & Innov 3X Levd ETN [BULZ] is up 43.59% over the past day.
Sell
48
FNGA alert for Apr 10
MicroSectors FANG+ Index 3X Leveraged ETN [FNGA] is up 39.42% over the past day.
Sell
47
FNGO alert for Apr 10
MicroSectors FANG+ Index 2X Leveraged ETN [FNGO] is up 27.34% over the past day.
